- Dec 12, 2000
- 24,810
- 9,015
- 136
Not Ernst Stavro Blofeld
Not Auric Goldfinger (though close!)
It's...Donald J. Trump!!!
As an American, I honestly appreciate this bold, audacious extension of "America First" to secure exclusive vaccine rights. But as a human being, this is pure unadulterated villainy by a despot.
--
The Trump administration has offered a German medical company “large sums of money” for exclusive access to a Covid-19 vaccine, German media have reported. The German government is trying to fight off what it sees as an aggressive takeover bid by the US, the broadsheet Die Welt reports, citing German government circles.
The US president had offered the Tübingen-based biopharmaceutical company CureVac “large sums of money” to gain exclusive access to their work, wrote Die Welt. According to an anonymous source quoted in the newspaper, Trump was doing everything to secure a vaccine against the coronavirus for the US, “but for the US only”.
...
On 11 March, CureVac released a statement that its CEO, the US citizen Daniel Menichella, was unexpectedly leaving the firm and would be replaced by the company’s [German] founder, Ingmar Hoerr.
At the start of the month, Menichella was invited to the White House in Washington to discuss strategy for the rapid development and production of a coronavirus vaccine with Trump, the vice-president, Mike Pence, and members of the White House coronavirus task force.
The White House has been contacted for comment.
Not Auric Goldfinger (though close!)
It's...Donald J. Trump!!!
As an American, I honestly appreciate this bold, audacious extension of "America First" to secure exclusive vaccine rights. But as a human being, this is pure unadulterated villainy by a despot.
--
Trump 'offers large sums' for exclusive US access to coronavirus vaccine
German government tries to fight off aggressive takeover bid by US, say reports
www.theguardian.com
The Trump administration has offered a German medical company “large sums of money” for exclusive access to a Covid-19 vaccine, German media have reported. The German government is trying to fight off what it sees as an aggressive takeover bid by the US, the broadsheet Die Welt reports, citing German government circles.
The US president had offered the Tübingen-based biopharmaceutical company CureVac “large sums of money” to gain exclusive access to their work, wrote Die Welt. According to an anonymous source quoted in the newspaper, Trump was doing everything to secure a vaccine against the coronavirus for the US, “but for the US only”.
...
On 11 March, CureVac released a statement that its CEO, the US citizen Daniel Menichella, was unexpectedly leaving the firm and would be replaced by the company’s [German] founder, Ingmar Hoerr.
At the start of the month, Menichella was invited to the White House in Washington to discuss strategy for the rapid development and production of a coronavirus vaccine with Trump, the vice-president, Mike Pence, and members of the White House coronavirus task force.
The White House has been contacted for comment.